Survival outcomes after surgical management of endometrial cancer: Analysis after the first 10‐year experience of robotic surgery in a single center

Objectives To report the 5‐year survival rates of patients undergone surgery for endometrial cancer, within a 10‐year study. Methods Single institution series with a minimum 2‐year follow‐up. The 5‐year survival outcomes of patients managed by robotics, laparoscopy and open surgery during the same period were compared. Multivariable analyses were performed to identify prognostic factors. Results Three hundred and sixty‐three consecutive patients were analysed. Open surgery showed a higher rate of abdominal recurrences (17.2% vs. 3.3%; p < 0.001); no differences were recorded in terms of vaginal, nodal or distant recurrences between open and minimally invasive surgery. At multivariable analyses, type II histology, peritoneal cytology and lympho‐vascular space invasion were independent predictors for survival. Based on each FIGO (The International Federation of Gynecology and Obstetrics) stage, no differences were found in terms of 5‐year disease‐free survival and overall survival between the approaches. Conclusions The surgical route does not affect the 5‐year survival in patients with endometrial cancer. Both robotics and laparoscopy are confirmed as viable options.